Article
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides
21 Dec 2024
Abstract excerpt
Endometrial cancer (EC) diagnosis traditionally relies on tumor morphology and nuclear grade, but personalized therapy demands a deeper understanding of tumor mutational burden (TMB), i.e., a key biomarker for immune checkpoint inhibition and immunotherapy response. Traditional TMB prediction methods, such as sequencing exomes or whole genomes, are costly and often unavailable in clinical settings. We present the...
Topics
Join the communities discussing this publication.
